Brief: Tela Bio Reports Third Quarter 2022 Financial Results
09/11/2022 21:07
TELA Bio Inc TELA.O :
* TELA BIO REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* TELA BIO INC Q3 REVENUE ROSE 46 PERCENT TO $11.2 MILLION
* TELA BIO INC- CONTINUE TO EXPECT FULL YEAR 2022 REVENUE TO
RANGE
FROM $42 MILLION TO $45 MILLION
* TELA BIO INC - QTRLY NET LOSS PER COMMON SHARE, BASIC AND
DILUTED $0.64
Source text for Eikon: ID:nGNXnFZkl
Further company coverage: TELA.O
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants